BSCI-02. METPlatform identifies brain metastasis vulnerabilities and predicts patient response to therapy

The diagnosis of brain metastasis involves high morbidity and mortality and remains an unmet clinical need in spite of being the most common tumor in the brain. Exclusion of these cancer patients from clinical trials is a major cause of their limited therapeutic options. We report a novel drug-scree...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Lucía, Blanco-Aparicio, Carmen, Bertero, Luca, Soffietti, Riccardo, Weiss, Tobias, Muñoz, Javier, Sepúlveda, Juan Manuel, Weller, Michael, Pastor, Joaquín, Valiente, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351295/
http://dx.doi.org/10.1093/noajnl/vdab071.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351295/
http://dx.doi.org/10.1093/noajnl/vdab071.001

Ejemplares similares